M. Sato

发表

Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.

M. Sato, J. Kim, L. Short, 1995, The Journal of pharmacology and experimental therapeutics.

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits.

R. L. Cain, D. Burr, C. Turner, 2001, Bone.

Application of automatic image segmentation to tibiae and vertebrae from ovariectomized rats.

G. Tysarczyk-Niemeyer, M. Sato, J. Helterbrand, 1997, Bone.

Differential Effects of Estrogen and Raloxifene on Messenger RNA and Matrix Metalloproteinase 2 Activity in the Rat Uterus

A. Geiser, J. Dodge, S. Estrem, 2005, Biology of reproduction.

Reduction in bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation.

A. Yamaguchi, M. Sato, T. Tanizawa, 2000, Bone.

Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.

R. Higgs, D. Burr, I. Owan, 1996, The Journal of pharmacology and experimental therapeutics.

Antiremodeling Agents Influence Osteoblast Activity Differently in Modeling and Remodeling Sites of Canine Rib

D. Burr, M. Allen, M. Sato, 2006, Calcified Tissue International.

Raloxifene and Vitamin K2 Combine to Improve the Femoral Neck Strength of Ovariectomized Rats

J. Iwamoto, T. Takeda, M. Sato, 2005, Calcified Tissue International.

The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys.

D. Burr, C. Turner, M. Sato, 2001, Advances in experimental medicine and biology.

Raloxifene preserves bone strength and bone mass in ovariectomized rats.

C. Turner, M. Sato, H. Bryant, 1994, Endocrinology.

Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.

J. Vahle, M. Sato, M. Westmore, 2002, Endocrinology.

Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator.

M. Sato, L. Short, H. Bryant, 1997, Journal of medicinal chemistry.

PINP: a serum biomarker of bone formation in the rat.

R. L. Cain, A. Geiser, J. Risteli, 2007, Bone.

Printed in U.S.A. Copyright © 1997 by The Endocrine Society Biosynthetic Human Parathyroid Hormone (1–34) Effects on Bone Quality in Aged Ovariectomized Rats

C. Turner, M. Sato, G. Zeng, 2022 .

Comparative x-ray densitometry of bones from ovariectomized rats.

M. Sato, 1995, Bone.

Three-dimensional Modeling of the Effects of Parathyroid Hormone on Bone Distribution in Lumbar Vertebrae of Ovariectomized Cynomolgus Macaques

C. Turner, M. Sato, M. Westmore, 2000, Osteoporosis International.

The effects of raloxifene on tibia histomorphometry in ovariectomized rats.

R. Turner, M. Sato, H. Bryant, 1994, Endocrinology.

Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.

M. Sato, H. Bryant, Masahiko Sato, 1996, Endocrinology.

Emerging therapies for the prevention or treatment of postmenopausal osteoporosis.

C. Turner, J. Dodge, M. Sato, 1999, Journal of medicinal chemistry.

Molecular determinants of tissue selectivity in estrogen receptor modulators.

C. D. Jones, K. Matsumoto, J. Dodge, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.

H W Cole, M. Sato, L. Short, 1998, Journal of medicinal chemistry.

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

D. Williams, M. Sato, Masahiko Sato, 1994, The Journal of clinical investigation.

Title Impaired expression of non-collagenous bone matrix protein mRNAs during fracture healing in ascorbic acid-deficient rats

T. Ochi, S. Hirota, Y. Kitamura, 2022 .

Effects of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] on Cortical Bone in Postmenopausal Women With Osteoporosis

J. Zanchetta, M. Sato, G. Gaich, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.

C. Turner, T. Wang, M. Sato, 1998, The Journal of pharmacology and experimental therapeutics.

Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.

C. Turner, R. Turner, M. Sato, 1998, Endocrinology.

Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene.

A. Geiser, C. Turner, M. Sato, 1998, Bone.

Analysis of Ovariectomy and Estrogen Effects on Body Composition in Rats by X‐Ray and Magnetic Resonance Imaging Techniques

B. Tomanek, L. Ryner, J. Sharp, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Selective Oestrogen Receptor Modulator, LY362321, is Not Neuroprotective in a Rat Model of Transient Focal Ischaemia

J. Dodge, H. Carswell, T. Farr, 2008, Journal of neuroendocrinology.

Effects of wortmannin analogs on bone in vitro and in vivo.

J. Dodge, C. Vlahos, W. Matter, 1996, The Journal of pharmacology and experimental therapeutics.